Page 3 - Jays Duker News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team - EyePoint Pharmaceuticals (NASDAQ:EYPT)

– Stuart Duty appointed to EyePoint's Board of Directors – – George Elston promoted to Executive Vice President – WATERTOWN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc.

United statesChristina tartagliaGeorge elstonJays dukerAmy phillipsEyepoint pharmaceuticals incOccidental collegeGuggenheim securitiesBetta pharmaceuticalsPiper jaffrayJuniper pharmaceuticals incGreen room communicationsCompany compensation committeeExchange commissionHead of corporate developmentPace university

EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team

EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJays dukerChristina tartagliastern irdirectGeorge elstonBetta pharmaceuticalsGuggenheim securitiesOptherion incEyepoint pharmaceuticalsHarvard business schoolPiper jaffrayAlimera sciencesExchange commissionCompany compensation committeeHead of corporate developmentJuniper pharmaceuticals incHead of corporate development at enzyvant therapeutics

EyePoint reports positive interim safety data for diabetic retinopathy, wet AMD treatment

EyePoint reports positive interim safety data for diabetic retinopathy, wet AMD treatment
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Jays dukerHeather bieleEyepoint pharmaceuticalsPoint pharmaceuticals

EyePoint Pharmaceuticals (EYPT) Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023

EyePoint Pharmaceuticals (EYPT) Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jays dukerEyepoint pharmaceuticals incEyepoint pharmaceuticalsChief executive officer

EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023

- Interim analysis of masked data shows EYP-1901 is well tolerated with no reported drug-related ocular or systemic serious adverse events in Phase 2 PAVIA clinical trial in non-proliferative diabetic.

United statesChristina tartagliaAmy phillipsJays dukerGlobenewswire incBetta pharmaceuticalsEyepoint pharmaceuticals nasdaqEyepoint pharmaceuticals incAlimera sciencesEyepoint pharmaceuticalsExchange commissionGreen room communicationsEquinox sciencesPoint pharmaceuticalsChief executive officerPrivate securities litigation reform act